Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 898 of 6351
-
New antibody drug could open door to kidney transplants for Hard-to-Match patients
Disease control OngoingThe purpose of this study is to determine whether vonsetamig will safely decrease anti-HLA antibodies to allow for kidney transplantation. Vonsetamig is being studied for treatment of patients in need of kidney transplantation who are highly sensitized to HLA. The study is look…
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Stomach bug treatment in teens could stop cancer before it starts
Disease control Recruiting nowGastric cancer remains a global health problem, and Chile has one of the highest GC mortality rates in the region. Helicobacter pylori (H. pylori) infection is ubiquitous in Chilean adults, and it constitutes the main cause of GC worldwide. A long-term process occurs from premali…
Sponsor: Miguel O'Ryan Gallardo • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Blood test may spare thousands of kids from unnecessary CT scans after head injury
Diagnosis CompletedMild traumatic brain injury (TBI), defined by a Glasgow Coma Scale (GCS) score of 13 to 15, is the cause of many consultations in paediatric emergency departments (1), even though it is a rare cause of acute complication: approximately 10% of children present with intracranial le…
Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Spinal implant may tackle pain and blood pressure together
Disease control Recruiting nowThe purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) pr…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a drug duo tame a rare eye cancer that has spread?
Disease control Stopped earlyThe purpose of this study is to evaluate the efficacy of lenvatinib and pembrolizumab to treat metastatic uveal melanoma.
Phase 2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New blood thinner cocktails aim to outsmart stroke in High-Risk patients
Disease control OngoingThe primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Phase 3 • Sponsor: University of Florida • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer mutation
Disease control OngoingThis is a prospective, single-arm, multicenter, phase II study to investigate the efficacy and safety of Ensartinib plus Bevacizumab in metastatic anaplastic lymphoma kinase (ALK)-rearranged Non-Small Cell Lung Cancer (NSCLC) with TP53 mutation.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a One-Two punch of heat and drainage tame inoperable bile duct cancer?
Disease control CompletedThis prospective clinical trial aims to assess the feasibility, efficacy, and safety of a personalized radiofrequency ablation protocol coupled with complete biliary drainage for patients presenting with inoperable perihilar cholangiocarcinoma.
Sponsor: Clinical Hospital Colentina • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a new sedative make bronchoscopy safer and smoother?
Symptom relief CompletedBronchoscopy may cause coughing, discomfort, body movement, and changes in breathing or blood pressure. Propofol is commonly used for sedation during bronchoscopy, but it may cause respiratory depression, circulatory depression, and injection pain. Ciprofol is another intravenous…
Phase 4 • Sponsor: Wenzhou Central Hospital • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can Ozone-Infused blood ease sleeplessness after a stroke?
Symptom relief CompletedThe purpose of this study is to observe the efficacy and safety of ozonated autohemotherapy in patients of post-ischemic stroke insomnia and to explore its mechanism of action.
Sponsor: Mengmeng Chen • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
One shot for boys could slash HPV in tanzania
Prevention Recruiting nowAdd-Vacc is an unblinded cluster-randomised trial (CRT) with two arms: (i) the national HPV vaccination programme (girls aged \~14 years, control arm) and (ii) the national programme plus single-dose male HPV vaccination given to a multi-year cohort of boys (intervention arm). Th…
Phase 4 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Prevention
Last updated Sep 09, 2026 23:00 UTC
-
Shorter PTSD therapy shows promise for veterans who drop out early
Symptom relief CompletedCognitive Processing Therapy (CPT) consists of discrete therapeutic components that are delivered across 12 sessions, but most Veterans never reach session 12, and those who drop out receive only 4 sessions on average. Veterans drop out because of time constraints, logistics, and…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New drug duo aims to tame rare blood disorder
Disease control OngoingThis study is researching a clinical treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on people with paroxysmal nocturnal hemoglobinuria (PNH). The aim of the study is to see how safe and effective the pozelimab + cemdisiran …
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hope for leukemia patients: drug targets hidden cancer cells after transplant
Disease control Recruiting nowAs part of postremission consolidative therapy, the decision to proceed with hematopoietic stem cell transplantation is a recommendable regimen in ALL therapy. However, The recurrence rate is high after transplantation. Minimal Residual Disease (MRD) is an important factor affect…
Phase 2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New stem cell infusion could boost transplant success in rare blood disorder
Disease control By invitation onlyEfficacy and Safety of Sequential Infusion of Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multicenter, Randomized, Phase 1 Trial
Phase 1/2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Talking about the end: could guided conversations reduce futile cancer treatments?
Symptom relief Recruiting nowPatients diagnosed with hematologic cancer are at substantial risk of dying, as 5-year survival among patients with acute myeloid leukemia is 20 % and only every second patient treated for incurable myeloma lives 5 years after date of diagnosis. Nevertheless, many overestimate th…
Sponsor: Christoffer Johansen • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New heart valve device aims to fix tricuspid disease
Disease control Recruiting nowThe Pivotal Study of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve). This study follows the EFS and is now to determine the safety and efficacy of the Cormatrix Cor TRICUSPID Valve for any patients requiring surgical replacement of the tricuspid valve.
Sponsor: Corvivo Cardiovascular, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:38 UTC
-
Could lying on the stomach help infants breathe easier?
Disease control Recruiting nowThe main objective is to determine the short-term effect of prone positioning in infants with infection-associated severe acute respiratory distress syndrome. The investigators compare oxygenation parameters and measurements from electrical impedance tomography (EIT) and lung ult…
Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for chinese men with tough prostate cancer: targeted drug takes on standard care
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of Olaparib compared with standard of care (Enzalutamide or Abiraterone Acetate) in Chinese men with metastatic castration-resistant prostate cancer who have failed prior treatment with a new hormonal agent and have…
Phase 4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental drug aims to slow lung scarring in IPF
Disease control OngoingThis is a randomized, double-blinded, placebo-controlled multicenter study to evaluate the safety and efficacy of DWN12088 in patients with Idiopathic Pulmonary Fibrosis.
Phase 2 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC